Nature neuroscience · 2018
Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Girdhar Kiran, Hoffman Gabriel E, Jiang Yan, Brown Leanne, Kundakovic Marija, Hauberg Mads E, Francoeur Nancy J, Wang Ying-Chih, Shah Hardik, Kavanagh David H, Zharovsky Elizabeth, Jacobov Rivka, Wiseman Jennifer R, Park Royce, Johnson Jessica S, Kassim Bibi S, Sloofman Laura, Mattei Eugenio, Weng Zhiping, Sieberts Solveig K, Peters Mette A, Harris Brent T, Lipska Barbara K, Sklar Pamela, Roussos Panos, Akbarian Schahram
Аннотация
Risk variants for schizophrenia affect more than 100 genomic loci, yet cell- and tissue-specific roles underlying disease liability remain poorly characterized. We have generated for two cortical areas implicated in psychosis, the dorsolateral prefrontal cortex and anterior cingulate cortex, 157 reference maps from neuronal, neuron-depleted and bulk tissue chromatin for two histone marks associated with active promoters and enhancers, H3-trimethyl-Lys4 (H3K4me3) and H3-acetyl-Lys27 (H3K27ac). Differences between neuronal and neuron-depleted chromatin states were the major axis of variation in histone modification profiles, followed by substantial variability across subjects and cortical areas. Thousands of significant histone quantitative trait loci were identified in neuronal and neuron-depleted samples. Risk variants for schizophrenia, depressive symptoms and neuroticism were significantly over-represented in neuronal H3K4me3 and H3K27ac landscapes. Our Resource, sponsored by PsychENCODE and CommonMind, highlights the critical role of cell-type-specific signatures at regulatory and disease-associated noncoding sequences in the human frontal lobe.